NCT01912560View on ClinicalTrials.gov

Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia

PHASE2CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
DyslipidemiaHypercholesterolemiaHypertriglyceridemia
Interventions
DRUG

CAT-2003

DRUG

Placebo

DRUG

Statin

All patients being treated with a stable dose of a statin prior to enrollment continue on their dosing regimen.

Trial Locations (14)

27609

Raleigh

27612

Raleigh

32223

Jacksonville

32792

Winter Park

33143

Miami

35662

Muscle Shoals

40213

Louisville

45219

Cincinnati

45227

Cincinnati

45246

Cincinnati

66160

Kansas City

90057

Los Angeles

04120

Auburn

G1V 4M6

Sainte-Foy

Sponsors
All Listed Sponsors
lead

Catabasis Pharmaceuticals

INDUSTRY

NCT01912560 - Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia | Biotech Hunter | Biotech Hunter